Published in Br J Pharmacol on November 01, 1981
Ultrastructural localization of high-affinity choline transporter in the rat anteroventral thalamus and ventral tegmental area: differences in axon morphology and transporter distribution. J Comp Neurol (2010) 0.82
Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance. Neurochem Int (2013) 0.80
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation. J Anat (1962) 8.63
Intracellular distributions of acetylcholine and choline acetylase. J Physiol (1958) 3.42
High affinity transport of choline into synaptosomes of rat brain. J Neurochem (1973) 2.35
Choline uptake systems of rat brain synaptosomes. Biochim Biophys Acta (1973) 1.88
Sodium-dependent high affinity choline uptake: a regulatory step in the synthesis of acetylcholine. J Neurochem (1976) 1.65
Depression of acetylcholine release from cerebral cortical slices by cholinesterase inhibition and by oxotremorine. Nat New Biol (1973) 1.52
Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol (1978) 1.30
High affinity choline transport and acetylCoA production in brain and their roles in the regulation of acetylcholine synthesis. Brain Res (1979) 1.16
Action of physostigmine (eserine) sulfate on peripheral nerve. Am J Physiol (1956) 1.04
The extraction of acetylcholine in small samples of cerebral tissue. J Pharm Pharmacol (1963) 1.00
The output per stimulus of acetylcholine from cerebral cortical slices in the presence or absence of cholinesterase inhibition. Br J Pharmacol (1974) 1.00
Stimulating action of atropine on the release of acetylcholine by rat cerebral cortex in vitro. Br J Pharmacol (1971) 0.99
Types of pharmacological action at autonomic ganglia. Arch Int Pharmacodyn Ther (1954) 0.99
Activation of high-affinity choline uptake in vitro by depolarizing agents. Mol Pharmacol (1976) 0.96
The effect of cholinergic drugs on [3H]acetylcholine release from slices of rat hippocampus, striatum and cortex. Brain Res (1977) 0.95
Release of [3H]acetylcholine from rat hippocampal slices: effect of septal lesion and of graded concentrations of muscarnic agonists and antagonists. Brain Res (1977) 0.95
Utilization of sodium-dependent high affinity choline uptake in vitro as a measure of the activity of cholinergic neurons in vivo. Life Sci (1975) 0.94
Mechanisms controlling choline transport and acetylcholine synthesis in motor nerve terminals during electrical stimulation. J Gen Physiol (1979) 0.93
Modulation of synaptosomal high affinity choline transport. Life Sci (1976) 0.89
Acetylcholine metabolism and choline uptake in cortical slices. J Neurochem (1977) 0.88
On the relationship between (3H)choline uptake activation and (3H)acetylcholine release. J Neurochem (1977) 0.86
Acceleration of choline uptake after depolarization-induced acetylcholine release in rat cortical synaptosomes. J Neurochem (1978) 0.85
Regulation of acetylcholine synthesis: does cytoplasmic acetylcholine control high affinity choline uptake? Science (1976) 0.84
Effect of pretreatment under various cationic conditions on acetylcholine content and choline transport in rat whole brain synaptosomes. J Neurochem (1978) 0.80
The action of acetylcholine and cholinesterase inhibitors on single axons of the lobsters. Biochem Pharmacol (1968) 0.78
Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem (2001) 2.63
Vagal non-adrenergic inhibition of guinea-pig stomach. J Physiol (1971) 2.29
The effect of catecholamines and sympathetic stimulation on the release of acetylcholine from the guinea-pig colon. Br J Pharmacol (1969) 1.81
Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease. J Autoimmun (1999) 1.70
Laparoscopic cholecystectomy in the third trimester of pregnancy. Am Surg (1996) 1.60
Intestinal perforation as a long-term complication of plug and mesh inguinal hernioplasty: case report. Hernia (2004) 1.58
Prognostic factors of malignant mesothelioma of the pleura. Cancer (1993) 1.58
Effects of novelty and habituation on acetylcholine, GABA, and glutamate release from the frontal cortex and hippocampus of freely moving rats. Neuroscience (2001) 1.50
Pharmacokinetics and efficacy of ropivacaine continuous wound instillation after joint replacement surgery. Br J Anaesth (2003) 1.49
Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest (1993) 1.46
Allergic vasculitis Gougerot-Ruiter syndrome. Arch Dermatol (1967) 1.44
A new selective antagonist of the nociceptin receptor. Br J Pharmacol (1998) 1.41
TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy. Antimicrob Agents Chemother (2000) 1.41
Effect of gluten-free diet on bone mineral content in growing patients with celiac disease. Am J Clin Nutr (1993) 1.37
Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J Med Chem (1997) 1.36
Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Mol Med (1995) 1.34
Noradrenaline inhibition of acetylcholine release from guinea-pig brain. Eur J Pharmacol (1978) 1.30
Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry (1985) 1.26
Further evidence for the presence of non-adrenergic inhibitory structures in the guinea-pig colon. Eur J Pharmacol (1968) 1.26
Macroamylasemia attributable to gluten-related amylase autoantibodies: a case report. Pediatrics (2001) 1.24
Alternative promoter and 5' exon generate a novel Gs alpha mRNA. J Biol Chem (1990) 1.23
Dose-related hemodynamic and renal effects of dopamine in congestive heart failure. Am Heart J (1974) 1.22
Sexually transmitted diseases and risk of HIV infection. Acta Derm Venereol (1996) 1.22
Asbestos content of lung tissue, lymph nodes, and pleural plaques from former shipyard workers. Am Rev Respir Dis (1990) 1.20
Adenosine decreases aspartate and glutamate release from rat hippocampal slices. Eur J Pharmacol (1984) 1.19
Characterization of [Nphe(1)]nociceptin(1-13)NH(2), a new selective nociceptin receptor antagonist. Br J Pharmacol (2000) 1.18
Murine model of accelerated transplant arteriosclerosis. Circ Res (1994) 1.18
The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology (1999) 1.17
Effects of metoclopramide on isolated guinea-pig colon. 2. Interference with ganglionic stimulant drugs. Eur J Pharmacol (1970) 1.16
Extracellular adenosine concentrations during in vitro ischaemia in rat hippocampal slices. Br J Pharmacol (1999) 1.16
Percutaneous endovascular abdominal aortic aneurysm repair: methods and initial outcomes from the first prospective, multicenter trial. J Cardiovasc Surg (Torino) (2011) 1.16
Bowel frequency in healthy children. Acta Paediatr Scand (1989) 1.16
Effect of psychoactive drugs on the output of acetylcholine from the cerebral cortex of the cat. Eur J Pharmacol (1968) 1.15
Investigations into the acetylcholine output from the cerebral cortex of the cat in the presence of hyoscine. Br J Pharmacol Chemother (1967) 1.15
The possible influences of B2A2 and B3A2 BCR/ABL protein structure on thrombopoiesis in chronic myeloid leukaemia. Eur J Cancer (2000) 1.15
Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid beta-peptide (1-42) into rat brain: implications for Alzheimer's disease. Neuroscience (2005) 1.14
A prospective, longitudinal study of the long-term effect of treatment on bone density in children with celiac disease. J Pediatr (2001) 1.13
The effects of modafinil on striatal, pallidal and nigral GABA and glutamate release in the conscious rat: evidence for a preferential inhibition of striato-pallidal GABA transmission. Neurosci Lett (1998) 1.12
Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol Biochem Behav (1996) 1.11
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow delta antagonists to manifest mu agonism or mu antagonism. J Med Chem (1999) 1.11
On status badges and quality signals in the paper wasp Polistes dominulus: body size, facial colour patterns and hierarchical rank. Proc Biol Sci (2008) 1.10
Tiny genomes and endoreduplication in Strepsiptera. Insect Mol Biol (2004) 1.09
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay. Br J Pharmacol (1998) 1.07
Clinical and socio-economic impact of influenza and respiratory syncytial virus infection on healthy children and their households. Clin Microbiol Infect (2005) 1.07
Reduction in myocardial ischemia with nitroglycerin or nitroglycerin plus phenylephrine administered during acute myocardial infarction. N Engl J Med (1975) 1.06
Inhibition of cortical acetylcholine release and cognitive performance by histamine H3 receptor activation in rats. Br J Pharmacol (1996) 1.06
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity. J Med Chem (1997) 1.05
Increased pulmonary vascular contraction to serotonin after cardiopulmonary bypass: role of cyclooxygenase. J Surg Res (2000) 1.04
Increased proteolytic processing of protein tyrosine phosphatase mu in confluent vascular endothelial cells: the role of PC5, a member of the subtilisin family. Biochemistry (1996) 1.04
The vigilance promoting drug modafinil increases dopamine release in the rat nucleus accumbens via the involvement of a local GABAergic mechanism. Eur J Pharmacol (1996) 1.04
Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations. Int J Antimicrob Agents (2001) 1.03
The cerebral acetylcholine release in conscious rabbits with semi-permanently implanted epidural cups. Int J Neuropharmacol (1968) 1.03
Investigation on acetylcholine, aspartate, glutamate and GABA extracellular levels from ventral hippocampus during repeated exploratory activity in the rat. Neurochem Res (2003) 1.03
Modafinil: an antinarcoleptic drug with a different neurochemical profile to d-amphetamine and dopamine uptake blockers. Biol Psychiatry (1997) 1.02
Effects of morphine on brain and spinal acetylcholine levels and nociceptive threshold in the frog. Brain Res (1974) 1.02
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist. J Med Chem (1998) 1.02
Exenatide: a review from pharmacology to clinical practice. Diabetes Obes Metab (2009) 1.02
Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. Neuroscience (1999) 1.01
Nodular vasculitis: immunofluorescent study; 7S gamma-globulin and complement (beta-1c-globulin) in lesions of nodular vasculitis. J Invest Dermatol (1966) 1.01
The mouse vas deferens: a pharmacological preparation sensitive to nociceptin. Eur J Pharmacol (1996) 1.00
Taurine distribution in cat brain. J Neurochem (1972) 1.00
Regional changes of acetylcholine and choline acetylase activity in the guinea-pig's brain after scopolamine. Experientia (1964) 0.99
Investigations into the adenosine outflow from hippocampal slices evoked by ischemia-like conditions. J Neurochem (1993) 0.99
Ring chromosome and latent centromeres. Cytogenet Cell Genet (1980) 0.99
The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. Neuroreport (1997) 0.99
Enhanced acetylcholine release in the hippocampus and cortex during acquisition of an operant behavior. Brain Res (1996) 0.99
Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors. Int J Immunopathol Pharmacol (2003) 0.99
Pain in ambulatory patients with lung or colon cancer. Prevalence, characteristics, and effect. Cancer (1992) 0.98
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo. Neuroscience (2003) 0.98
The effect of naloxone on opioid-induced inhibition and facilitation of acetylcholine release in brain slices. Br J Pharmacol (1982) 0.97
III Italian Consensus Conference on Malignant Mesothelioma of the Pleura. Epidemiology, Public Health and Occupational Medicine related issues. Med Lav (2015) 0.97
Body composition in children with celiac disease and the effects of a gluten-free diet: a prospective case-control study. Am J Clin Nutr (2000) 0.95
A comparison of asbestos burden in lung parenchyma, lymph nodes, and plaques. Ann N Y Acad Sci (1991) 0.95
Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats. Neuroscience (1997) 0.95
Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing. Arch Dis Child (1991) 0.95
Control of inflammation and prophylaxis of endophthalmitis after cataract surgery: a multicenter study. Eur J Ophthalmol (2007) 0.95
The striatal neurotensin receptor modulates striatal and pallidal glutamate and GABA release: functional evidence for a pallidal glutamate-GABA interaction via the pallidal-subthalamic nucleus loop. J Neurosci (1998) 0.95
Inhibitory effect of nociceptin on [3H]-5-HT release from rat cerebral cortex slices. Br J Pharmacol (1999) 0.94
Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study. Neurochem Res (2004) 0.94
Reversal of low bone density with a gluten-free diet in children and adolescents with celiac disease. Am J Clin Nutr (1998) 0.94
Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients. Am J Gastroenterol (1999) 0.94
A2 adenosine receptors: their presence and neuromodulatory role in the central nervous system. Gen Pharmacol (1996) 0.94
Oxiracetam prevents electroshock-induced decrease in brain acetylcholine and amnesia. Eur J Pharmacol (1986) 0.94
Selective opioid dipeptides. Biochem Biophys Res Commun (1994) 0.94
Modulation of 5-hydroxytryptamine efflux from rat cortical synaptosomes by opioids and nociceptin. Br J Pharmacol (2000) 0.94
Fate of [125I]angiotensin II in adrenal zona glomerulosa cells. Endocrinology (1986) 0.94